293 related articles for article (PubMed ID: 27154255)
1. Solid microcrystalline dispersion films as a new strategy to improve the dissolution rate of poorly water soluble drugs: A case study using olanzapine.
Modica de Mohac L; de Fátima Pina M; Raimi-Abraham BT
Int J Pharm; 2016 Jul; 508(1-2):42-50. PubMed ID: 27154255
[TBL] [Abstract][Full Text] [Related]
2. The influence of drug physical state on the dissolution enhancement of solid dispersions prepared via hot-melt extrusion: a case study using olanzapine.
Pina MF; Zhao M; Pinto JF; Sousa JJ; Craig DQ
J Pharm Sci; 2014 Apr; 103(4):1214-23. PubMed ID: 24765654
[TBL] [Abstract][Full Text] [Related]
3. Third-generation solid dispersion combining Soluplus and poloxamer 407 enhances the oral bioavailability of resveratrol.
Vasconcelos T; Prezotti F; Araújo F; Lopes C; Loureiro A; Marques S; Sarmento B
Int J Pharm; 2021 Feb; 595():120245. PubMed ID: 33484925
[TBL] [Abstract][Full Text] [Related]
4. A New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME.
Huang S; O'Donnell KP; Keen JM; Rickard MA; McGinity JW; Williams RO
AAPS PharmSciTech; 2016 Feb; 17(1):106-19. PubMed ID: 26335416
[TBL] [Abstract][Full Text] [Related]
5. Effect of composition in the development of carbamazepine hot-melt extruded solid dispersions by application of mixture experimental design.
Djuris J; Ioannis N; Ibric S; Djuric Z; Kachrimanis K
J Pharm Pharmacol; 2014 Feb; 66(2):232-43. PubMed ID: 24350884
[TBL] [Abstract][Full Text] [Related]
6. Curcumin nanoparticles containing poloxamer or soluplus tailored by high pressure homogenization using antisolvent crystallization.
Homayouni A; Amini M; Sohrabi M; Varshosaz J; Nokhodchi A
Int J Pharm; 2019 May; 562():124-134. PubMed ID: 30898640
[TBL] [Abstract][Full Text] [Related]
7. Solubilization and formulation of chrysosplenol C in solid dispersion with hydrophilic carriers.
Ng CL; Lee SE; Lee JK; Kim TH; Jang WS; Choi JS; Kim YH; Kim JK; Park JS
Int J Pharm; 2016 Oct; 512(1):314-321. PubMed ID: 27593897
[TBL] [Abstract][Full Text] [Related]
8. Solubility and bioavailability enhancement study of lopinavir solid dispersion matrixed with a polymeric surfactant - Soluplus.
Zi P; Zhang C; Ju C; Su Z; Bao Y; Gao J; Sun J; Lu J; Zhang C
Eur J Pharm Sci; 2019 Jun; 134():233-245. PubMed ID: 31028820
[TBL] [Abstract][Full Text] [Related]
9. Soluplus®/TPGS-based solid dispersions prepared by hot-melt extrusion equipped with twin-screw systems for enhancing oral bioavailability of valsartan.
Lee JY; Kang WS; Piao J; Yoon IS; Kim DD; Cho HJ
Drug Des Devel Ther; 2015; 9():2745-56. PubMed ID: 26045660
[TBL] [Abstract][Full Text] [Related]
10. Dissolution rate enhancement and physicochemical characterization of carbamazepine-poloxamer solid dispersions.
Medarević DP; Kachrimanis K; Mitrić M; Djuriš J; Djurić Z; Ibrić S
Pharm Dev Technol; 2016; 21(3):268-76. PubMed ID: 25582577
[TBL] [Abstract][Full Text] [Related]
11. Enhanced dissolution and bioavailability of Nateglinide by microenvironmental pH-regulated ternary solid dispersion: in-vitro and in-vivo evaluation.
Wairkar S; Gaud R; Jadhav N
J Pharm Pharmacol; 2017 Sep; 69(9):1099-1109. PubMed ID: 28590055
[TBL] [Abstract][Full Text] [Related]
12. Enhanced dissolution and bioavailability of grapefruit flavonoid Naringenin by solid dispersion utilizing fourth generation carrier.
Khan AW; Kotta S; Ansari SH; Sharma RK; Ali J
Drug Dev Ind Pharm; 2015 May; 41(5):772-9. PubMed ID: 24669978
[TBL] [Abstract][Full Text] [Related]
13. Increased dissolution and oral absorption of itraconazole/Soluplus extrudate compared with itraconazole nanosuspension.
Zhang K; Yu H; Luo Q; Yang S; Lin X; Zhang Y; Tian B; Tang X
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1285-92. PubMed ID: 23562534
[TBL] [Abstract][Full Text] [Related]
14. Fusion Method for Solubility and Dissolution Rate Enhancement of Ibuprofen Using Block Copolymer Poloxamer 407.
Dugar RP; Gajera BY; Dave RH
AAPS PharmSciTech; 2016 Dec; 17(6):1428-1440. PubMed ID: 26817763
[TBL] [Abstract][Full Text] [Related]
15. The Combined Use of Imaging Approaches to Assess Drug Release from Multicomponent Solid Dispersions.
Punčochová K; Ewing AV; Gajdošová M; Pekárek T; Beránek J; Kazarian SG; Štěpánek F
Pharm Res; 2017 May; 34(5):990-1001. PubMed ID: 27573574
[TBL] [Abstract][Full Text] [Related]
16. Development of the Binary and Ternary Atorvastatin Solid Dispersions:
Faraji E; Mohammadi M; Mahboobian MM
Biomed Res Int; 2021; 2021():6644630. PubMed ID: 34527740
[TBL] [Abstract][Full Text] [Related]
17. Formulation development, characterization, and evaluation of bedaquiline fumarate - Soluplus
Pardhi VP; Patel M; Jain K
Pharm Dev Technol; 2024 Jun; 29(5):492-503. PubMed ID: 38682603
[TBL] [Abstract][Full Text] [Related]
18. Preparation and characterization of domperidone solid dispersions.
Essa EA; Balata GF
Pak J Pharm Sci; 2012 Oct; 25(4):783-91. PubMed ID: 23009995
[TBL] [Abstract][Full Text] [Related]
19. Hot-melt extrusion for enhanced delivery of drug particles.
Miller DA; McConville JT; Yang W; Williams RO; McGinity JW
J Pharm Sci; 2007 Feb; 96(2):361-76. PubMed ID: 17075869
[TBL] [Abstract][Full Text] [Related]
20. Preparation of lapatinib ditosylate solid dispersions using solvent rotary evaporation and hot melt extrusion for solubility and dissolution enhancement.
Hu XY; Lou H; Hageman MJ
Int J Pharm; 2018 Dec; 552(1-2):154-163. PubMed ID: 30268849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
